EAM

Exome Asset Management Portfolio holdings

AUM $151M
1-Year Est. Return 46.2%
This Quarter Est. Return
1 Year Est. Return
+46.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$151M
AUM Growth
+$41.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
85
New
Increased
Reduced
Closed

Top Buys

1
+$5.44M
2
+$4.27M
3
+$3.75M
4
ARWR icon
Arrowhead Research
ARWR
+$3.6M
5
CVS icon
CVS Health
CVS
+$3.29M

Top Sells

1
+$3.18M
2
+$2.99M
3
+$2.93M
4
VSTM icon
Verastem
VSTM
+$2.49M
5
GERN icon
Geron
GERN
+$2.13M

Sector Composition

1 Healthcare 97.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTYX icon
51
Ventyx Biosciences
VTYX
$622M
$188K 0.11%
+60,600
IMUX icon
52
Immunic
IMUX
$79.9M
$153K 0.09%
+173,900
ACAD icon
53
Acadia Pharmaceuticals
ACAD
$4.64B
– –
0
ALT icon
54
Altimmune
ALT
$547M
– –
0
ALVO icon
55
Alvotech
ALVO
$1.7B
– –
-78,372
ANAB icon
56
AnaptysBio
ANAB
$1.23B
– –
-15,000
APLS icon
57
Apellis Pharmaceuticals
APLS
$2.99B
– –
-98,600
ARCT icon
58
Arcturus Therapeutics
ARCT
$203M
– –
0
BCRX icon
59
BioCryst Pharmaceuticals
BCRX
$1.6B
– –
-172,883
CLDX icon
60
Celldex Therapeutics
CLDX
$1.96B
– –
-73,000
CMPS
61
Compass Pathways
CMPS
$559M
– –
-213,544
CRNX icon
62
Crinetics Pharmaceuticals
CRNX
$4.43B
– –
-62,700
DYN icon
63
Dyne Therapeutics
DYN
$2.9B
– –
-195,933
ELDN icon
64
Eledon Pharmaceuticals
ELDN
$119M
– –
-114,145
ELEV
65
DELISTED
Elevation Oncology
ELEV
– –
-110,353
GPCR icon
66
Structure Therapeutics
GPCR
$2.1B
– –
-53,744
KPTI icon
67
Karyopharm Therapeutics
KPTI
$98M
– –
0
LEGN icon
68
Legend Biotech
LEGN
$5.2B
– –
-29,100
MREO
69
Mereo BioPharma
MREO
$328M
– –
0
NAMS icon
70
NewAmsterdam Pharma
NAMS
$4B
– –
-36,574
NKTR icon
71
Nektar Therapeutics
NKTR
$1.16B
– –
0
NVO icon
72
Novo Nordisk
NVO
$213B
– –
0
OEF icon
73
iShares S&P 100 ETF
OEF
$29.1B
– –
0
PGEN icon
74
Precigen
PGEN
$1.27B
– –
0
PPH icon
75
VanEck Pharmaceutical ETF
PPH
$1.15B
– –
0
1 2
3
4